Skip to main content

CORRECTION article

Front. Pharmacol., 31 March 2022
Sec. Renal Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.894462
This article is part of the Research Topic Insights in Renal Pharmacology: 2021 View all 18 articles

Corrigendum: The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

This article is a correction to:

  1. The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

    1. Read original article
Ming-Hsien Tsai,&#x;Ming-Hsien Tsai1,2†Mingchih Chen,&#x;Mingchih Chen3,4†Yen-Chun Huang,Yen-Chun Huang3,4Hung-Hsiang LiouHung-Hsiang Liou5Yu-Wei Fang, Yu-Wei Fang1,2*
  • 1Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei City, Taiwan
  • 2Department of Medicine, School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan
  • 3Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, New Taipei City, Taiwan
  • 4AI Development Center, Fu Jen Catholic University, New Taipei City, Taiwan
  • 5Division of Nephrology, Department of Internal Medicine, Hsin-Jen Hospital, New Taipei City, Taiwan

A corrigendum on
The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

by Tsai, M.-H., Chen, M., Huang, Y.-C., Liou, H.-H., and Fang, Y.-W. (2022). Front. Pharmacol. 12:804000. doi:10.3389/fphar.2021.804000

In the published article, Mingchih Chen was incorrectly included as a corresponding author. The only corresponding author should be Yu-Wei Fang.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: dialysis, National Health Insurance Research Database, lipid-lowering agents, mortality, major adverse cardiovascular events

Citation: Tsai M-H, Chen M, Huang Y-C, Liou H-H and Fang Y-W (2022) Corrigendum: The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study. Front. Pharmacol. 13:894462. doi: 10.3389/fphar.2022.894462

Received: 11 March 2022; Accepted: 17 March 2022;
Published: 31 March 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Tsai, Chen, Huang, Liou and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yu-Wei Fang, m005916@gmail.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.